位置:首页 > 蛋白库 > CLGN_MOUSE
CLGN_MOUSE
ID   CLGN_MOUSE              Reviewed;         611 AA.
AC   P52194; Q80YU3; Q9D2K5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 182.
DE   RecName: Full=Calmegin;
DE   AltName: Full=A2/6;
DE   AltName: Full=Calnexin-T;
DE   AltName: Full=MEG 1 antigen;
DE   Flags: Precursor;
GN   Name=Clgn; Synonyms=Meg1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CALCIUM-BINDING, DEVELOPMENTAL STAGE, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=ICR; TISSUE=Testis;
RX   PubMed=8126001; DOI=10.1016/s0021-9258(17)37349-0;
RA   Watanabe D., Yamada K., Nishina Y., Tajima Y., Koshimizu U., Nagata A.,
RA   Nishimune Y.;
RT   "Molecular cloning of a novel Ca(2+)-binding protein (calmegin)
RT   specifically expressed during male meiotic germ cell development.";
RL   J. Biol. Chem. 269:7744-7749(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CALCIUM-BINDING, AND TISSUE SPECIFICITY.
RC   STRAIN=CD-1; TISSUE=Testis;
RX   PubMed=8188695; DOI=10.1016/s0021-9258(17)36765-0;
RA   Ohsako S., Hayashi Y., Bunick D.;
RT   "Molecular cloning and sequencing of calnexin-t. An abundant male germ
RT   cell-specific calcium-binding protein of the endoplasmic reticulum.";
RL   J. Biol. Chem. 269:14140-14148(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=9434179; DOI=10.1016/s0378-1119(97)00537-4;
RA   Tanaka H., Ikawa M., Tsuchida J., Nozaki M., Suzuki M., Fujiwara T.,
RA   Okabe M., Nishimune Y.;
RT   "Cloning and characterization of the human Calmegin gene encoding putative
RT   testis-specific chaperone.";
RL   Gene 204:159-163(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=9177349; DOI=10.1038/42484;
RA   Ikawa M., Wada I., Kominami K., Watanabe D., Toshimori K., Nishimune Y.,
RA   Okabe M.;
RT   "The putative chaperone calmegin is required for sperm fertility.";
RL   Nature 387:607-611(1997).
RN   [7]
RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=10495883; DOI=10.1679/aohc.62.283;
RA   Yoshinaga K., Tanii I., Toshimori K.;
RT   "Molecular chaperone calmegin localization to the endoplasmic reticulum of
RT   meiotic and post-meiotic germ cells in the mouse testis.";
RL   Arch. Histol. Cytol. 62:283-293(1999).
RN   [8]
RP   FUNCTION, DISRUPTION PHENOTYPE, INTERACTION WITH ADAM1B AND ADAM2, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11784061; DOI=10.1006/dbio.2001.0462;
RA   Ikawa M., Nakanishi T., Yamada S., Wada I., Kominami K., Tanaka H.,
RA   Nozaki M., Nishimune Y., Okabe M.;
RT   "Calmegin is required for fertilin alpha/beta heterodimerization and sperm
RT   fertility.";
RL   Dev. Biol. 240:254-261(2001).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15151931; DOI=10.1095/biolreprod.104.028647;
RA   Nakanishi T., Isotani A., Yamaguchi R., Ikawa M., Baba T., Suarez S.S.,
RA   Okabe M.;
RT   "Selective passage through the uterotubal junction of sperm from a mixed
RT   population produced by chimeras of calmegin-knockout and wild-type male
RT   mice.";
RL   Biol. Reprod. 71:959-965(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=16870943; DOI=10.1095/biolreprod.106.052977;
RA   Yamaguchi R., Yamagata K., Ikawa M., Moss S.B., Okabe M.;
RT   "Aberrant distribution of ADAM3 in sperm from both angiotensin-converting
RT   enzyme (Ace)- and calmegin (Clgn)-deficient mice.";
RL   Biol. Reprod. 75:760-766(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-578; SER-580; SER-582;
RP   SER-592 AND SER-595, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Brain, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Functions during spermatogenesis as a chaperone for a range
CC       of client proteins that are important for sperm adhesion onto the egg
CC       zona pellucida and for subsequent penetration of the zona pellucida.
CC       Required for normal sperm migration from the uterus into the oviduct.
CC       Required for normal male fertility. Binds calcium ions.
CC       {ECO:0000269|PubMed:11784061, ECO:0000269|PubMed:15151931,
CC       ECO:0000269|PubMed:16870943, ECO:0000269|PubMed:9177349}.
CC   -!- SUBUNIT: Interacts with PDILT and PPIB (By similarity). Interacts with
CC       ADAM2. Interacts with ADAM1A, ADAM1B and ADAM3; these are protein-
CC       coding genes in mouse but may be pseudogenes in other organisms.
CC       {ECO:0000250, ECO:0000269|PubMed:11784061}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10495883}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:10495883}.
CC   -!- TISSUE SPECIFICITY: Detected in testis (at protein level). Detected in
CC       testis. {ECO:0000269|PubMed:11784061, ECO:0000269|PubMed:8126001,
CC       ECO:0000269|PubMed:8188695, ECO:0000269|PubMed:9177349,
CC       ECO:0000269|PubMed:9434179}.
CC   -!- DEVELOPMENTAL STAGE: Specifically expressed during male meiotic germ
CC       cell development. First detected in early pachytene spermatocytes.
CC       Expression is highest in elongating and round spermatids and decreases
CC       thereafter. Not detectable in mature spermatids.
CC       {ECO:0000269|PubMed:10495883, ECO:0000269|PubMed:8126001}.
CC   -!- DISRUPTION PHENOTYPE: Male mice show normal mating behavior and produce
CC       morphologically normal sperm, but are nearly sterile. Mutant sperm fail
CC       to adhere to the egg zona pellucida and are generally unable to
CC       penetrate the egg extracellular matrix. In addition, mutant sperm
CC       display defects in migration from the uterus into the oviduct.
CC       {ECO:0000269|PubMed:11784061, ECO:0000269|PubMed:15151931,
CC       ECO:0000269|PubMed:9177349}.
CC   -!- SIMILARITY: Belongs to the calreticulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D14117; BAA03180.1; -; mRNA.
DR   EMBL; U08373; AAA20599.1; -; mRNA.
DR   EMBL; D86323; BAA22591.1; -; mRNA.
DR   EMBL; AK019534; BAB31782.1; ALT_SEQ; mRNA.
DR   EMBL; BC050767; AAH50767.1; -; mRNA.
DR   CCDS; CCDS22452.1; -.
DR   PIR; A53418; A53418.
DR   PIR; A54086; A54086.
DR   RefSeq; NP_001316556.1; NM_001329627.1.
DR   RefSeq; NP_034034.2; NM_009904.4.
DR   RefSeq; XP_011246600.1; XM_011248298.2.
DR   AlphaFoldDB; P52194; -.
DR   SMR; P52194; -.
DR   BioGRID; 198750; 1.
DR   DIP; DIP-47581N; -.
DR   IntAct; P52194; 4.
DR   MINT; P52194; -.
DR   STRING; 10090.ENSMUSP00000105457; -.
DR   iPTMnet; P52194; -.
DR   PhosphoSitePlus; P52194; -.
DR   MaxQB; P52194; -.
DR   PaxDb; P52194; -.
DR   PeptideAtlas; P52194; -.
DR   PRIDE; P52194; -.
DR   ProteomicsDB; 283382; -.
DR   Antibodypedia; 16228; 194 antibodies from 29 providers.
DR   DNASU; 12745; -.
DR   Ensembl; ENSMUST00000002259; ENSMUSP00000002259; ENSMUSG00000002190.
DR   Ensembl; ENSMUST00000109831; ENSMUSP00000105457; ENSMUSG00000002190.
DR   GeneID; 12745; -.
DR   KEGG; mmu:12745; -.
DR   UCSC; uc009mkd.1; mouse.
DR   CTD; 1047; -.
DR   MGI; MGI:107472; Clgn.
DR   VEuPathDB; HostDB:ENSMUSG00000002190; -.
DR   eggNOG; KOG0675; Eukaryota.
DR   GeneTree; ENSGT00950000182915; -.
DR   HOGENOM; CLU_018224_2_0_1; -.
DR   InParanoid; P52194; -.
DR   OMA; RVGCGEW; -.
DR   OrthoDB; 775337at2759; -.
DR   PhylomeDB; P52194; -.
DR   TreeFam; TF300618; -.
DR   BioGRID-ORCS; 12745; 2 hits in 72 CRISPR screens.
DR   ChiTaRS; Clgn; mouse.
DR   PRO; PR:P52194; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; P52194; protein.
DR   Bgee; ENSMUSG00000002190; Expressed in spermatocyte and 69 other tissues.
DR   Genevisible; P52194; MM.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0044183; F:protein folding chaperone; IMP:MGI.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0007339; P:binding of sperm to zona pellucida; IMP:MGI.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0065003; P:protein-containing complex assembly; IMP:MGI.
DR   GO; GO:0007338; P:single fertilization; IGI:MGI.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IBA:GO_Central.
DR   Gene3D; 2.10.250.10; -; 1.
DR   InterPro; IPR001580; Calret/calnex.
DR   InterPro; IPR018124; Calret/calnex_CS.
DR   InterPro; IPR009033; Calreticulin/calnexin_P_dom_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   PANTHER; PTHR11073; PTHR11073; 1.
DR   Pfam; PF00262; Calreticulin; 1.
DR   PRINTS; PR00626; CALRETICULIN.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF63887; SSF63887; 1.
DR   PROSITE; PS00803; CALRETICULIN_1; 1.
DR   PROSITE; PS00804; CALRETICULIN_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Calcium; Chaperone; Developmental protein; Differentiation;
KW   Disulfide bond; Endoplasmic reticulum; Meiosis; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Spermatogenesis; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..611
FT                   /note="Calmegin"
FT                   /id="PRO_0000004211"
FT   TOPO_DOM        20..471
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        472..492
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        493..611
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          267..280
FT                   /note="1-1"
FT   REPEAT          284..297
FT                   /note="1-2"
FT   REPEAT          303..316
FT                   /note="1-3"
FT   REPEAT          322..335
FT                   /note="1-4"
FT   REPEAT          339..352
FT                   /note="2-1"
FT   REPEAT          356..369
FT                   /note="2-2"
FT   REPEAT          370..383
FT                   /note="2-3"
FT   REPEAT          384..397
FT                   /note="2-4"
FT   REGION          254..335
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          317..350
FT                   /note="Interaction with PPIB"
FT                   /evidence="ECO:0000250"
FT   REGION          517..611
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        266..297
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        310..333
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        518..604
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         128
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   MOD_RES         561
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14967"
FT   MOD_RES         578
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         580
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         592
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         595
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         602
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P27824"
FT   DISULFID        151..185
FT                   /evidence="ECO:0000250"
FT   DISULFID        351..355
FT                   /evidence="ECO:0000250"
FT   CONFLICT        76..79
FT                   /note="LSKA -> YQS (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        87
FT                   /note="E -> Q (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127
FT                   /note="E -> D (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        133..135
FT                   /note="ADK -> GAIN (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        201
FT                   /note="K -> Q (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        210
FT                   /note="A -> P (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        291
FT                   /note="R -> K (in Ref. 1; BAA03180, 2; AAA20599 and 3;
FT                   BAA22591)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        350
FT                   /note="A -> D (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        432
FT                   /note="E -> D (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        436
FT                   /note="A -> P (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        440
FT                   /note="A -> P (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        445
FT                   /note="E -> D (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        451
FT                   /note="A -> T (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        522
FT                   /note="E -> D (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        549
FT                   /note="V -> L (in Ref. 2; AAA20599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        577..578
FT                   /note="LS -> AE (in Ref. 4; BAB31782)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   611 AA;  69431 MW;  D70A3C418229DA00 CRC64;
     MRFQGVGLCL GLLFITVNAD FMDDGVEVED FSENSDESNI KDEPSSGTFK YKTPQPIGEV
     YFTETFDSGN LAGWVLSKAK KDDMDSEIAI YDGRWEIEEL KENQVPGDRG LVLKSKAKHH
     AIAAVLEKPF IFADKPLIVQ YEVNFQDGID CGGAYIKLLA DTGDLILENF YDKTSYTIMF
     GPDKCGEDYK LHLIFRHKHP KTGVFEEKHA KPPDVDLKEF FTDRKTHLYT LVMNPDDTFE
     VLIDQKVVNQ GTLLDDVVPP INPPREIDDP SDKKPEEWDD RAKIPDPTAV RPEDWDENEP
     AQIEDSSAVK PDGWLDDEPK FIPNPKAEKP EDWSDDMDGE WEAPHIPNPA CQIGCGEWKP
     PMIDNPKYKG IWRPPMINNP NYQGLWSPQK IPNPDYFEDD HPFLLTSFSA LGLELWSMTP
     DIYFDNFIIC SEKEVADQWA TDGWELKIMV ANANEPGVLR QLVIAAEERP WLWLMYLVMA
     GLPVALVASF CWPRKVKKKY EDTGPKKTEL CKLQSKAALE QEAEEEKAPE KPEDVQEEKK
     PGEAEVVTVE KEVIGEPEEK SKEDRETLEG QEEVSKLSKS GSEDEMKDAD ESPGSGDAPL
     KSLRKRRVRK D
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024